Dr. Hadi S. Chohan, M.D.
Pulmonology (Pulmonary Disease Physician)
- Medicare participating
At a glance
- Years since graduation
- 18
- In the NPI registry since
- 2008
- Medicare patients seen, 2024
- 330
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pulmonary Disease Physician primary
FL license ME118775 -
Critical Care Medicine (Internal Medicine) Physician
FL license ME118775 -
Internal Medicine Physician
FL license ME118775
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Adventhealth Orlando Orlando, FL
- Orlando Health Orlando, FL
- Orlando Health South Lake Hospital Clermont, FL
- Orlando Health-Health Central Hospital Ocoee, FL
Medical groups
- Orlando Health Medical Group Inc (2,287 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 330
- Services billed
- 857
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 939 | 416 |
| Established patient office or other outpatient visit, 30-39 minutes | 442 | 296 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 325 | 214 |
| Established patient office or other outpatient visit, 20-29 minutes | 221 | 178 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 172 | 170 |
| Critical care, first 30-74 minutes | 161 | 99 |
| Test to measure expiratory airflow and volume | 148 | 147 |
| X-ray of chest, 2 views | 146 | 132 |
| Test to determine lung volumes using sensors | 136 | 136 |
| Test to examine how well the lungs exchange gases | 136 | 136 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in Altamonte Springs, FL | 244 |
| Trelegy Ellipta (fluticasone/umeclidin/vilanter) Other prescribers in Altamonte Springs, FL | 226 |
| Montelukast Sodium Other prescribers in Altamonte Springs, FL | 87 |
| Sildenafil Citrate Other prescribers in Altamonte Springs, FL | 67 |
| Ventolin Hfa (albuterol sulfate) Other prescribers in Altamonte Springs, FL | 65 |
| Azithromycin Other prescribers in Altamonte Springs, FL | 48 |
| Anoro Ellipta (umeclidinium brm/vilanterol tr) Other prescribers in Altamonte Springs, FL | 41 |
| Adempas (riociguat) | 40 |
| Symbicort (budesonide/formoterol fumarate) Other prescribers in Altamonte Springs, FL | 39 |
| Orenitram Er (treprostinil diolamine) | 37 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 12 companies reported 56 payments worth $30,296 in total to this clinician.
| United Therapeutics Corporation | $20,600 |
|---|---|
| Merck Sharp & Dohme LLC | $8,765 |
| Actelion Pharmaceuticals US, Inc. | $554 |
| Liquidia Technologies, Inc. | $80.51 |
| GE Healthcare | $62.60 |
| GlaxoSmithKline, LLC. | $49.98 |
| Insmed, Inc. | $49.24 |
| Takeda Pharmaceuticals U.S.A., Inc. | $35.56 |
| Compensation for services other than consulting (speaking, faculty) | $26,828 |
|---|---|
| Food and Beverage | $2,331 |
| Travel and Lodging | $1,017 |
| Education | $120 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC May 14, 2025 | Compensation for services other than consulting (speaking, faculty) WINREVAIR · CARDIOVASCULAR | $4,770 |
| United Therapeutics Corporation Aug 1, 2025 | Compensation for services other than consulting (speaking, faculty) | $3,960 |
| United Therapeutics Corporation Jun 16, 2025 | Compensation for services other than consulting (speaking, faculty) | $3,960 |
| United Therapeutics Corporation Jun 13, 2025 | Compensation for services other than consulting (speaking, faculty) TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun | $3,960 |
| United Therapeutics Corporation Nov 4, 2025 | Compensation for services other than consulting (speaking, faculty) | $3,960 |
| Merck Sharp & Dohme LLC Oct 3, 2025 | Compensation for services other than consulting (speaking, faculty) WINREVAIR · CARDIOVASCULAR | $3,578 |
| United Therapeutics Corporation Nov 11, 2025 | Compensation for services other than consulting (speaking, faculty) | $2,640 |
| United Therapeutics Corporation May 27, 2025 | Travel and Lodging travel to Bonita Springs, FL · in-kind | $208 |
| United Therapeutics Corporation Jun 16, 2025 | Travel and Lodging TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun · travel to Jacksonville, FL | $179 |
| United Therapeutics Corporation Jun 4, 2025 | Travel and Lodging travel to Bonita Springs, FL | $168 |
All 20 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| United Therapeutics Corporation Nov 13, 2025 | Travel and Lodging travel to Ormond Beach, FL | $74.90 |
| United Therapeutics Corporation Nov 11, 2025 | Compensation for services other than consulting (speaking, faculty) | $2,640 |
| United Therapeutics Corporation Nov 5, 2025 | Travel and Lodging travel to Saint Augustine, FL | $137 |
| United Therapeutics Corporation Nov 4, 2025 | Compensation for services other than consulting (speaking, faculty) | $3,960 |
| Merck Sharp & Dohme LLC Oct 21, 2025 | Education WINREVAIR · CARDIOVASCULAR · in-kind | $25.70 |
| Merck Sharp & Dohme LLC Oct 21, 2025 | Education WINREVAIR · CARDIOVASCULAR · in-kind | $25.70 |
| Merck Sharp & Dohme LLC Oct 21, 2025 | Education WINREVAIR · CARDIOVASCULAR · in-kind | $25.70 |
| Merck Sharp & Dohme LLC Oct 21, 2025 | Education WINREVAIR · CARDIOVASCULAR · in-kind | $25.70 |
| Merck Sharp & Dohme LLC Oct 3, 2025 | Compensation for services other than consulting (speaking, faculty) WINREVAIR · CARDIOVASCULAR | $3,578 |
| Insmed, Inc. Aug 18, 2025 | Education in-kind | $17.38 |
| United Therapeutics Corporation Aug 5, 2025 | Travel and Lodging travel to The Villages, FL | $84.70 |
| United Therapeutics Corporation Aug 1, 2025 | Compensation for services other than consulting (speaking, faculty) | $3,960 |
| United Therapeutics Corporation Jun 16, 2025 | Compensation for services other than consulting (speaking, faculty) | $3,960 |
| United Therapeutics Corporation Jun 16, 2025 | Travel and Lodging TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun · travel to Jacksonville, FL | $179 |
| United Therapeutics Corporation Jun 13, 2025 | Compensation for services other than consulting (speaking, faculty) TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun | $3,960 |
| United Therapeutics Corporation Jun 4, 2025 | Travel and Lodging travel to Bonita Springs, FL | $168 |
| United Therapeutics Corporation May 27, 2025 | Travel and Lodging travel to Bonita Springs, FL · in-kind | $208 |
| Merck Sharp & Dohme LLC May 14, 2025 | Compensation for services other than consulting (speaking, faculty) WINREVAIR · CARDIOVASCULAR | $4,770 |
| Merck Sharp & Dohme LLC May 14, 2025 | Travel and Lodging WINREVAIR · CARDIOVASCULAR · travel to Jacksonville, FL | $150 |
| United Therapeutics Corporation Mar 10, 2025 | Travel and Lodging travel to Bonita Springs, FL · in-kind | $15.91 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $300 in research payments for these studies, mostly to the institutions running them.
- Study to Evaluate Symptoms of Exocrine Pancreatic Insufficiency in Adult Participants With Cystic Fibrosis or Chronic Pancreatitis Treated With Creon
AbbVie Inc. · Completed · NCT05069597
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.